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Abstract
A peripheral primitive neuroectodermal tumor (pPNET) is a small round cell tumor occurring mostly in children or
young adults and categorized into the Ewing sarcoma family of tumors. pPNETs originating from the pancreas are
especially rare, and only 25 cases have been reported in the literature. We report a case of a 22-year-old man who
had a giant expansive tumor located in the uncinate process of the pancreas, 80 mm in diameter resulting in
obstruction in the duodenum. The patient underwent a pancreaticoduodenectomy. The histological examination
showed that the pancreatic tumor was composed of atypical small round cells. Immunohistochemical findings were
positive for CD99. An Ewing sarcoma breakpoint region 1 gene 22q12 rearrangement was proven by a two-color
fluorescence in situ hybridization assay. We diagnosed the tumor as a pPNET of the pancreas, which, according to
the literature, is highly aggressive with poor prognosis. A multidisciplinary approach to treat these neoplasms
should improve the prognoses.
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Background
Peripheral primitive neuroectodermal tumors (pPNETs)
are primary malignant neoplasms, usually occurring in
children or young adults. These neoplasms are small
round cell tumors arising from primitive neuroepithelial
stem cells and categorized into the Ewing sarcoma fam-
ily of tumors (ESFTs), which display common character-
istics of morphology, histology, and genetics [1]. While
the Ewing’s sarcoma is a primary bone tumor, pPNETs
occur mostly in the soft tissue of the thoracopulmonary
region, pelvis, and lower extremities [2]. pPNETs origin-
ating from the pancreas are extremely rare. To our
knowledge, only 25 cases have been reported in the
literature. Herein, we report a surgical case of a giant
pPNET in the pancreas.
Case presentation
A 22-year-old man, who presented with symptoms of
upper abdominal discomfort and nausea during the pre-
vious month, was admitted to the emergency depart-
ment of our hospital with extremely severe upper
abdominal pain. He was obese with a BMI of 32.5.
Laboratory data on admission showed slight anemia
(hemoglobin 8.6 g/dL) but no elevation of bilirubin and
low or normal amounts of several tumor markers, such
as carcinoembryonic antigen (CEA), carbohydrate anti-
gen 19-9 (CA19-9), and DUPAN-2. He did not show any
metabolic abnormalities.
Contrast-enhanced computed tomography (CT) scan
revealed that a giant tumor 80 mm in diameter with
mild enhancement occupied the pancreatic head. The
tumor invaded the third portion of the duodenum, and
the oral side of the duodenum was expanded. The super-
ior mesenteric vein was shifted forward, and the inferior
vena cava was squeezed by the expansive tumor (Fig. 1).
Magnetic resonance imaging (MRI) showed that the
tumor was homogenous and isointense on T1-weighted
* Correspondence: kumamoto@kitasato-u.ac.jp
Department of Surgery, Kitasato University School of Medicine, 1-15-1
Kitasato, Minami-ku, Sagamihara, Kanagawa 252-0374, Japan
© 2015 Nishizawa et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made.
Nishizawa et al. Surgical Case Reports  (2015) 1:80 
DOI 10.1186/s40792-015-0084-7
images (Fig. 2a) compared with the pancreas while slightly
high intense on T2-weighted images (Fig. 2b). The tumor
showed abnormal high intensity on diffusion-weighted im-
ages (Fig. 2c). Fast imaging employing steady-state acquisi-
tion (FIESTA) showed that the tumor was located slightly
distal from the bile duct in the pancreas (Fig. 2d). In mag-
netic resonance cholangiopancreatography (MRCP), the
common bile duct was not dilated and the main
pancreatic duct was not depicted because it was too nar-
row (Fig. 2e). Positron-emission tomography with 18-
fluorodeoxyglucose (FDG-PET) scanning showed a high
accumulation of FDG in the tumor. The maximum stan-
dardized uptake value (SUV max) was 18.61, and there
were no findings of metastasis (Fig. 3). Gastrointestinal
endoscopy showed a gentle protuberance with mucosal
reddening in the third portion of the duodenum, and the
Fig. 1 Contrast-enhanced CT of the abdomen. a The tumor was located mainly in the uncinate process of the pancreas and invaded the duodenum.
The oral side of the duodenum was expanded. b The tumor excluded the inferior vena cava with no evidence of direct invasion. c The arterial phase:




Fig. 2 MRI of the abdomen. a T1-weighted images showed an isointense tumor compared with the pancreas. b T2-weighted images showed a
slightly hyperintense homogenous tumor. c Diffusion-weighted images showed a hyperintense tumor. d FIESTA showed that the tumor edge
(the red arrow) and the common bile duct in the pancreas (the yellow arrow) were located slightly distant. e MRCP showed that the common bile
duct was not expanded and the main pancreatic duct was not depicted because it was too narrow
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endoscope could not pass through. A biopsy was done
from this region. At the same time, endoscopic
ultrasound-guided fine needle aspiration was done. Based
on cytohistological findings, acinar cell carcinoma or
PNET was suspected; however, a definitive diagnosis was
difficult because of inadequate samples. We planned an
operation because it would be possible to accomplish
complete resection of the tumor, which showed an expan-
sive growth. We performed a pylorus-preserving pancrea-
ticoduodenectomy (Whipple resection).
Macroscopically, the lesion presented as a light gray
solid tumor which was 85 mm × 52 mm × 62 mm in size
and occupied the uncinate process of the pancreas
(Fig. 4a). Microscopic examination showed that the pan-
creatic tumor was composed of atypical small round
cells with scant cytoplasm, and each had a round nu-
cleus with a distinct nuclear membrane (Fig. 4b). The
tumor cells invaded the duodenum and retroperitoneal
fat tissue directly, and the retroperitoneal margin was
histologically positive. There were aggressive lymphovas-
cular invasions and lymph node metastases in 4 of 15
lymph nodes. Immunohistochemistry findings were
strongly positive for CD99 (Fig. 4c), weekly positive for
neuron-specific enolase, neural cell adhesion molecule,
vimentin, synaptophysin, and CAM5.2, while negative
for chromogranin A, cytokeratin AE1/AE3, cytokeratin
7, cytokeratin 20, carbohydrate antigen 19-9, CD10, and
progesterone receptor. In addition, an Ewing sarcoma
breakpoint region 1 gene, 22q12 rearrangement was
proven by a two-color fluorescence in situ hybridization
(FISH) assay (Fig. 4d). Finally, we diagnosed the tumor
as a pPNET of the pancreas.
The patient developed postoperative complications
such as a pancreatic fistula and a poor appetite and was
treated conservatively. He recovered somewhat and was
discharged 60 days after the surgery and transferred to a
specialized facility for further adjuvant therapies.
Discussion
pPNET was first described by Stout [3] in 1918 as a
tumor of the ulnar nerve with the gross features of a
sarcoma but composed of small round cells focally
arranged as rosettes. On the other hand, Ewing’s sar-
coma was first reported in 1921 by Ewing [4], which was
an undifferentiated small round cell tumor that mostly
occurred in the bones of children. However, recent
advances of genetic investigation revealed that Ewing’s
sarcoma and pPNET showed the same chromosomal
translocations as t(11;22)(q24;q12), and both were classi-
fied into the same category of ESFTs by the World
Health Organization Classification in 2002 [5]. ESFTs
are made up of Ewing’s sarcoma, extraosseous Ewing’s
sarcoma, Askin’s tumor, and pPNET. pPNETs account
for approximately 1 % of all sarcomas [6] and 20 % of
malignant soft tissue tumors in children [7]. pPNETs
most often occur in soft tissues or bones. Although
pPNETs seldom arise in organs, there have been some
sporadic case reports of pPNETs arising in a variety of
organs, such as the kidney, urinary bladder, lung, uterus,
and vagina. Moreover, pPNETs arising in the pancreas
are extremely rare, accounting for only 0.3 % of primary
pancreatic neoplasms [8].
In reviewing the literature, 25 cases of pPNET of the
pancreas including the present case have been reported
to date (Table 1) [2, 8–24]. The mean age at diagnosis
was 18.2 ± 9.6 (2–37 years) and the median was 20 years
old, which was 12 years older than that in the retro-
spective study of 975 Ewing tumors of bones in Europe
[25]. There was no sexual predominance in the 25 cases
reviewed in the literature (13 males, 12 females). The
most common presenting finding was abdominal pain
(68 %), subsequently jaundice (20 %), nausea (16 %), and
anemia (16 %). Endocrine disorders such as hyperglycemia
and precocious puberty were accompanied in some cases.
The tumor commonly occurred in the pancreatic head
a b
Fig. 3 FDG-PET scanning of the abdomen and upper body. a The SUV max was 18.61. b There were no findings of metastases (yellow arrows)
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(68 %) and ranged in size from 35 to 220 mm (mean
88 mm), but supervened obstructive jaundice was seen in
only 29 % because of its expansive growth, quite different
from invasive growth like a ductal carcinoma.
Abdominal CT and MRI are the most useful modal-
ities to reveal these tumors. Tan et al. [26] reported the
radiographic characteristics of these tumors precisely, in
which typical cases showed as isodense or hypodense on
unenhanced CT, isointense on T1WI, and either isoin-
tense or hyperintense on T2WI as revealed by MRI. The
tumors usually had ill-defined borders and irregular
shapes with heterogeneous enhancement. The present
case was consistent with these findings.
The usefulness of FDG-PET was not determined.
Gyorke et al. [27] reported that FDG-PET was a valuable
method for the diagnosis of ESFT and PNET. To the con-
trary, Doi et al. [18] reported that PNET showed a low
level of SUV, and the detection sensitivity of FDG-PET
was lower than that of helical CT. In the present case, the
tumor showed a high level of SUV. An accumulation of
more cases is needed to definitively determine the useful-
ness of FDG-PET for PNETs.
A histopathological examination is important for the
diagnosis of pPNET. PNETs are small round cells and
express the product of the MIC2 gene on the X
chromosome, which is confirmed with antibodies, such
as CD99, O13, and 12E74. Moreover, another immuno-
histological analysis, such as neuron-specific enolase
(NSE), vimentin, or cytokeratin, would be required to
make a definitive diagnosis of pPNET. According to this
review, a positive rate for NSE on pPNET was 92.9 %
(13/14), that for vimentin was 88.9 % (8/9), that for cyto-
keratin AE1/AE3 was 57.1 % (8/14), and that for synap-
tophysin was 46.7 (7/15) (Table 2). The combination of
these histological features and immune cell changes lead
to an accurate diagnosis of pPNET.
The PNETs have a typical chromosome translocation in-
volving EWS gene loci on chromosome 22q12, located in
the 5′ sides of a chimera gene. Meanwhile, the 3′ sides of
a fusion gene are known as FLI1 t(11:22) (80–85 %), ERG
t(21:22) (5–15 %), ETV1 t(7:22) (rare), E1AF t(17:22)
(rare), and FEV t(2:22) (rare) [28, 29]. EWS gene encodes a
multifunctional protein that is involved in various cellular
processes, including gene expression, cell signaling, and
RNA processing and transport [30]. Chromosomal trans-
locations encoding transcription factors result in the pro-
duction of chimeric proteins that are involved in
tumorigenesis. The detection of the chimera gene assures
the diagnosis of pPNET and may be a useful prognostic




Fig. 4 Pathologic findings. a Gross appearance of the cut surface of the tumor. b The tumor was composed of atypical small round cells with
scant cytoplasm (hematoxylin and eosin staining, original magnification, ×100). The left side shows pancreatic acinar cells. c The tumor cells show
strong cytoplasmic membrane positivity to CD99 (immunohistochemical staining, original magnification, ×100). d Two-color FISH assay results.
The probe was localized to the breakpoints on chromosome 22q12 and provided evidence of the t(22q12) translocation by showing one red and
one green signal pattern on the derivative chromosome 22
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Table 1 Clinical features of primitive neuroectodermal tumors of the pancreas
Presenting finding













Danner [9] 17 M + Jaundice, nausea Head 90 Whipple resection 0/9 VDC/cisplatin + etoposide,
RAD
33 NED
Luttges [8] 13 F − Diarrhea Body 220 Whipple resection NA CHE NA NA
31 M + − Body NA Biopsy NA CHE NA NA
Bulchmann
[10]
6 F + Anemia Head 60 Whipple resectiona 2/2 NP 6 DOD
O’Sullivan [11] 20 F NA − Head 35 Whipple resection 4/34 CHE, RAD 30 AWD
Gemechu [12] 17 M − Abdominal swelling Body 120 Resection NA NP 36 NED
Movahedi [2] 20 M + Jaundice Head 35 Whipple resection NA NP 27 AWD
25 F + Jaundice Head NA Biopsy NA NA NA NA
21 F + NA Head NA Whipple resection Positive NP DOC DOC
25 F + Jaundice Head 80 Biopsy NA NA NA NA
13 M + NA Head 60 Biopsy NA VDC 43 NED
6 M + Jaundice Head 35 Whipple resection Positive VDC 48 DOD
Takeuchi [13] 10 F + Abdominal swelling Body 100 Biopsy NA CHE, surgery, AST 3 DOD
Perek [14] 31 M + Fever, abdominal
swelling
Head 120 Whipple resection None AI, ifosfamide, docetaxel 50 NED
Welsch [15] 33 M − Nausea and vomiting Body 150 Distal
pancreatecotomya
NA VIDE, VAI, melaphalan +
etoposide, AST
12 NED
Schutte [16] 2 F − Precocious puberty Body 60 Distal
pancreatecotomy
None VDC/AI 12 NED
Wakao [17] 3 M + Abdominal swelling Head 82 Biopsy NA CITA, VDC/IE, MEC, surgery,a
AST, RAD (30 Gy)
8 NED
Doi [18] 37 M − Jaundice Head 60 Whipple resection Positive VDC, IE, RAD 6 NED
Menon [19] 8 F + NA Body 100 Biopsy NA Doxorubicin, RAD 19 DOD
Jing [20] 24 F NA NA Head 100 Resection NA CHE, RAD NA NA
Maxwell [21] 11 M − Fatigue, anemia Head 98 Whipple resectiona NA VDC/IE 15 AWD












Table 1 Clinical features of primitive neuroectodermal tumors of the pancreas (Continued)
Reilly [23] 23 M + Nausea Body 58 Distal
pancreatecotomya
1/24 NA NA NA
Dias [24] 25 F + − Head 42 Whipple resection None VAI, VDC 8 DOD
Present case 22 M + Nausea, anemia Head 85 Whipple resectiona 4/15 CHE, RAD 12 AWD
− absent, + present, AI actinomycin D (dactinomycin)/ifosfamide, AST autologous stem cell transplantation, AWD alive with disease, CHE chemotherapy (details unknown), IE ifosfamide/etoposide, DOC died of postoperative
complication, DOD died of disease, F female, M male, MAID doxorubicin/dacarvazine/ifosfamide, MEC melphalan/etoposide/cisplatin, NA not available, NED no evidence of disease, NP not performed, RAD radiation, details
unknown, RUPT resection of the uncinated process tumor, VAC vincristine/actinomycin D (dactinomycin)/cyclophosphamide, VAI vincristine/actinomycin D (dactinomycin)/ifosfamide, VAIA vincristine/doxorubicin/ifosfamide
alternating with vincristine/actinomycin D (dactinomycin)/ifosfamide, VDC vincristine/doxorubicin/cyclophosphamide, VIDE vincristine/ifosfamide/doxorubicin/etoposide












gene: one is reverse transcript polymerase chain reaction
(RT-PCR) and the other is FISH. In RT-PCR analysis,
fresh or frozen tissues are better samples than formalin-
fixed, paraffin wax-embedded (FFPE) tissues. Yamaguchi
et al. [31] reported that the fusion transcripts could not al-
ways be detected by RT-PCR using FFPE tissue. Indeed,
there were two reports that stated that the extraction of
RNA could not be accomplished from formalin-fixed tis-
sues. On the other hand, FISH analysis could be per-
formed with FFPE tissues. The interphase FISH method
using Ewing sarcoma breakpoint region 1 (EWSR1) dual-
color, break-apart probes is sensitive and specific for the
detection of rearrangement of the EWS gene on chromo-
some 22q12, although the probes specifically identify
t(22q12) but cannot specifically identify the translocation
partners [31]. The detailed examination of the chimera
gene provides important information regarding prognosis
[1]. Thus, in a case of an operation on a young patient
suspected of a small round cell tumor or an
undifferentiated tumor, it is recommended to preserve fro-
zen samples of the tumor.
pPNETs are highly aggressive malignant tumors with
almost inevitable recurrence and metastases. Metastases
to the bone, bone marrow, lymph nodes, lung, liver, and
other organs have been reported. Currently, the standard
treatment of pPNETs is complete surgical resection with
an adequate margin. Ozaki et al. [32] reported that the
surgical resection for pPNET contributed to increase the
disease control rate and survival rate, regardless of radio-
therapy. However, with pPNETs originating from the pan-
creas, it is sometimes difficult to achieve complete
resection with a safe surgical margin because unresectable
organs, such as major vessels, are located adjacent to the
pancreas. In the present case, the retroperitoneal margin
was microscopically positive, as the anterior surface of the
inferior vena cava could have been. Therefore, periopera-
tive chemotherapy and radiotherapy play a great part
toward controlling this type of disease.
Table 2 Immunohistochemical features of primitive neuroectodermal tumors of the pancreas
Reference MIC-2 (CD99/O13/12E7) NSE AE1/AE3 VIM SYN CHR Cytogenetic analysis Chromosomal translocation
Danner [9] + + + NP − − RT-PCR EWS exon 7 to FLI1 exon6
Luttges [8] + + + + − − NA NA
+ + − + − − NA NA
Bulchmann [10] + + NP − − − FISH EWSR1
O’Sullivan [11] + NP − + NP NP RT-PCR EWS exon 7 to FLI1 exon5
Gemechu [12] NP NP NP NP + + NA NA
Movahedi [2] + + + NP − − RT-PCR EWS-FLI1
+ − + NP − − NA NA
+ + + NP + + RT-PCR EWS-FLI1
+ + NP NP − − RT-PCRa −
+ + − NP − − NA NA
+ + + NP + NP RT-PCR EWS-FLI1
Takeuchi [13] + + + NP NP NP RT-PCR EWS-FLI1
Perek [14] + NP NP + + − a −
Welsch [15] + + + + + NP FISH EWSR1
Schutte [16] + NP − + + + NA NA
Wakao [17] + NP NP NP NP NP RT-PCR EWS-FLI1
Doi [18] + + − + NP NP FISH EWSR1
Menon [19] + NA NA NA NA NP NA NA
Jing [20] NA NA NA NA NA NP NA NA
Maxwell [21] + NP + + − NP RT-PCR EWS-ERG
Mao [22] + + − NP − − RT-PCR EWS-FLI1
Reilly [23] + + + − − − RT-PCR EWS-FLI1
Dias [24] + NP NP NP − − FISH EWSR1
Present case + + − + + − FISH EWSR1
− absent, + present, AE1/AE3 cytokeratin AE1/AE3, CHR chromogranin A, EWSR1 Ewing sarcoma breakpoint region 1 gene one on 22q12, FISH fluorescence in situ
hybridization, NA not available, NP not performed, NSE neuron-specific enolase, RT-PCR reverse transcript polymerase chain reaction, SYN synaptophysin, VIM vimentin
aRNA exhaustion from a paraffin block was impossible
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Conclusions
We reported a case of an extremely rare tumor originating
from the pancreatic head in a young adult. When examin-
ing a young patient suspected of a small round cell tumor
or undifferentiated tumor, frozen samples of the tumor
should be used for a definitive diagnosis. Aggressive surgi-
cal resection in combination with chemotherapy and
radiotherapy is the current standard of treatment, but the
prognosis of this rare tumor remains unsatisfactory. To
improve the outcome, the accumulation of such cases and
further investigations are warranted.
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